ANESTHESIA MANAGEMENT IN DERMATOLOGICAL SURGERY: TECHNIQUES, CHALLENGES, AND COMPLICATIONS

Main Article Content

Dr. Y. Venkata Subbaiah
Dr Ahsan Mustafa

Keywords

Dermatological surgery, Local anesthesia, Tumescent local anesthesia (TLA), Regional nerve block, Office-based surgery, Ambulatory surgery, Conscious sedation, Intravenous sedation, Dexmedetomidine, Propofol, Midazolam, Local anesthetic systemic toxicity (LAST), Lidocaine toxicity, Patient safety, Perioperative anesthesia, Liposuction, Mohs micrographic surgery, Pain management, Airway management, Dermatologic anesthesia

Abstract

Background: Dermatological surgery has transitioned significantly from hospital operating theaters to office-based settings and ambulatory surgical centers. This shift requires anesthesia providers and dermatologic surgeons to possess a nuanced understanding of specialized anesthetic techniques tailored to diverse procedures, ranging from micrographic skin cancer excisions to extensive body-contouring liposuctions.


Objective: This comprehensive review synthesizes current anesthetic modalities utilized in dermatological surgery, evaluates procedural and patient-specific challenges, analyzes potential localized and systemic complications, and establishes evidence-based mitigation protocols.


Methods: A systematic review of contemporary literature regarding local anesthesia, regional nerve blocks, tumescent local anesthesia (TLA), and intravenous conscious sedation in dermatological subspecialties was performed. Extracted parameters focused on safety thresholds, drug toxicity dynamics, patient comorbidities, and adverse event management.


Results: Local and regional techniques remain the foundation of dermatological anesthesia, offering excellent targeted pain control with minimal systemic impact. Tumescent local anesthesia allows large-scale interventions (e.g., liposuction) without general anesthesia, though it introduces a risk of delayed lidocaine toxicity due to slow systemic absorption. Intravenous sedation options, such as dexmedetomidine, propofol, and midazolam, enhance patient compliance during long or high-anxiety procedures but necessitate strict airway monitoring. Key challenges include operating on elderly patients with extensive cardiovascular or pulmonary comorbidities and navigating complex facial anatomy. Primary complications range from benign vasovagal episodes to severe Local Anesthetic Systemic Toxicity (LAST) and epinephrine-induced hypertensive crises.


Conclusion: Anesthesia management in dermatological surgery demands a precise, patient-centric approach that balances surgical access with patient safety. By implementing strict weight-based dosing, keeping lipid emulsion rescue therapies readily available, and utilizing proper patient positioning, clinicians can effectively minimize risks and optimize outcomes in ambulatory and office-based settings.

Abstract 0 | PDF Downloads 0

References

1. Grekin RC, Auletta MJ. Local anesthesia in dermatologic surgery. J Am Acad Dermatol. 1988;19(4):599–614.
2. Klein JA. The tumescent technique for liposuction surgery. Am J Cosmet Surg. 1987;4(4):263–267.
3. Klein JA. Tumescent technique for regional anesthesia permits lidocaine doses of 35 mg/kg for liposuction. J Dermatol Surg Oncol. 1990;16(3):248–263.
4. Klein JA. Anesthesia for liposuction in dermatologic surgery. J Dermatol Surg Oncol. 1988;14(10):1124–1132.
5. Breuninger H, Hobbach PS, Schimek F. Ropivacaine: An important anesthetic agent for slow infusion and other forms of tumescent anesthesia. Dermatol Surg. 1999;25(10):799–802.
6. Moehrle M, Breuninger H. The use of tumescent local anesthesia in dermatosurgery. Dermatol Surg. 2001;27(6):581–585.
7. Moehrle M, Breuninger H. Dermatosurgery using subcutaneous infusion anesthesia with prilocaine and ropivacaine in children. Pediatr Dermatol. 2001;18(6):469–472.
8. Bussolin L, Busoni P, Giorgi L, et al. Tumescent local anesthesia for the surgical treatment of burns and post-burn sequelae in pediatric patients. Anesthesiology. 2003;99(6):1371–1375.
9. Häfner HM, Röcken M, Breuninger H. Epinephrine-supplemented local anesthetics for ear and nose surgery: Clinical use without complications in more than 10,000 surgical procedures. J Dtsch Dermatol Ges. 2005;3(3):195–199.
10. Upadya M, Upadya GM. Anesthesia for dermatological surgery. Indian J Dermatol Venereol Leprol. 2005;71(3):145–154. (PMC)
11. Butterwick KJ, Goldman MP. Lidocaine for dermatologic procedures: Pharmacology and clinical use. Dermatol Surg. 1995;21(8):701–709.
12. Alam M, Dover JS. Management of complications and safety in dermatologic surgery. Dermatol Clin. 2005;23(2):317–326.
13. Alam M, Ibrahim O, Nodzenski M, et al. Adverse events associated with mohs micrographic surgery: Multicenter prospective cohort study. JAMA Dermatol. 2013;149(12):1378–1385.
14. Kouba DJ, LoPiccolo MC, Alam M, Bordeaux JS, Cohen B, Hanke CW, et al. Guidelines for the use of local anesthesia in office-based dermatologic surgery. J Am Acad Dermatol. 2016;74(6):1201–1219.
15. Müller CSL, Tilgen W, Pföhler C. Pre- and perioperative aspects of dermatosurgery. J Dtsch Dermatol Ges. 2017;15(2):151–167.
16. Brown DL. Regional Anesthesia and Analgesia. Philadelphia: Saunders Elsevier; 2006.
17. Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC. Clinical Anesthesia. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
18. Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Young WL. Miller's Anesthesia. 8th ed. Philadelphia: Elsevier Saunders; 2015.
19. Neal JM, Bernards CM, Butterworth JF IV, Di Gregorio G, Drasner K, Hejtmanek MR, et al. ASRA Practice Advisory on Local Anesthetic Systemic Toxicity. Reg Anesth Pain Med. 2010;35(2):152–161.
20. Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: A multifactorial concept. Reg Anesth Pain Med. 2004;29(6):564–575.